Shots:
- AVITA Medical has received European MDR CE Mark approval for Recell Go to promote healing in burns & traumatic or surgical wounds; commercialization to begin in select EU states, incl. Germany, Italy, & the UK
- Recell Go is a point-of-care device that allows clinicians to create a suspension of a patient’s own skin cells from a small healthy sample for Spray-On Skin application, promoting healing in burns or wounds, & builds on the Recell System used in the EU
- Recell data presented at the EBA Congress’25 showed adults with deep partial-thickness burns had 36% shorter hospital stays vs traditional grafting
Ref: AVITA Medical | Image: AVITA Medical | Press Release
Related News:- AVITA Medical Launches Cohealyx for Wound Healing in the US
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
